OHSU

Tibor Kovacsovics, M.D.

Head Shot of Tibor Kovacsovics
Email: 
click here
Office: 
503 494-5058

Background

Dr. Kovacsovics research focuses on clinical trials with new agents for treatment of acute leukemias.


Selected Publications

"Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening," Cancer Research (Vol: 73, Issue: 1, Page 285-296) - 2013

"Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: Results from the CLASSIC I trial," Journal of Clinical Oncology (Vol: 30, Issue: 20, Page 2492-2499) - 2012

"Multiplex high-throughput gene mutation analysis in acute myeloid leukemia," Human Pathology (Vol: 43, Issue: 12, Page 2167-2176) - 2012

"Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia," Leukemia and Lymphoma (Vol: 53, Issue: 3, Page 435-440) - 2012

"RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia," Leukemia and Lymphoma (Vol: 53, Issue: 5, Page 999-1002) - 2012

 

Back to faculty list

OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


Contact

  Email Tibor Kovacsovics

503 494-5058

Memberships & Associations

American Society of Hematology hematology/oncology)